Morning Overview on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked ...
Immortality has fascinated humanity for millennia, from ancient myths of eternal youth to modern science fiction's promises of living forever. Today, the question is no longer confined to the realm of ...
In this week's "It's Debatable" segment, Rick Rosen and Charles Moster debate whether the achievement of human immortality is a legitimate scientific goal. Rosen retired as a professor from the Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results